Remdesivir Will Be Made Available to COVID-19 Patients Meeting Certain Clinical Criteria Selected NHS coronavirus patients will soon be able to access a treatment to speed up their recovery. Thanks to the joined-up efforts of the UK government, the devolved administrations, pharmaceutical company Gilead Sciences, the NHS, and the Medicines and Healthcare products Regulatory Agency (MHRA), the anti-viral drug remdesivir will be made available to patients meeting certain clinical criteria to support their recovery in hospital. The drug is currently undergoing clinical trials around the world, including in the UK, with early data showing it can shorten the time to recovery by about 4 days. https://www.technologynetworks.com/drug-discovery/news/remdesivir-will-be-made-available-to-covid-19-patients-meeting-certain-clinical-criteria-335267?utm_campaign=NEWSLETTER_TN_Breaking%20Science%20News&utm_medium=email&_hsmi=88545897&_hsenc=p2ANqtz-8n7foiA02D9eckSkjKtzapxvR0_TkMu0nxT50jrbf61fdsT7fqJdzUtU494ghLSdTLuyxREQv9hoQiqx6-MrdIj6Ma9Q&utm_content=88545897&utm_source=hs_email